Balloon dilation catheter for use in sinus passageways

Information

  • Patent Grant
  • 10369337
  • Patent Number
    10,369,337
  • Date Filed
    Tuesday, April 26, 2016
    8 years ago
  • Date Issued
    Tuesday, August 6, 2019
    4 years ago
Abstract
A balloon dilation catheter includes a substantially rigid inner guide member and a movable shaft coupled to a balloon that is slidably mounted on the substantially rigid inner guide member. To treat a sinus cavity of a subject using the balloon dilation the substantially rigid inner guide member is advanced into a drainage pathway of the sinus (e.g., frontal recess) of the subject via a nasal passageway. The shaft and balloon are advanced in a distal direction over the substantially rigid inner guide member to place the balloon in the drainage pathway. The balloon is inflated to expand or otherwise remodel the drainage pathway.
Description
FIELD OF THE INVENTION

The field of the invention generally relates to balloon inflation devices and methods. More particularly, the field of the invention relates to balloon dilation devices and methods for the treatment of sinusitis.


BACKGROUND OF THE INVENTION

Sinusitis is a condition affecting over 35 million Americans, and similarly large populations in the rest of the developed world. Sinusitis occurs when one or more of the four paired sinus cavities (i.e., maxillary, ethmoid, frontal, sphenoid) becomes obstructed, or otherwise has compromised drainage. Normally the sinus cavities, each of which are lined by mucosa, produce mucous which is then moved by beating cilia from the sinus cavity out to the nasal cavity and down the throat. The combined sinuses produce approximately one liter of mucous daily, so the effective transport of this mucous is important to sinus health.


Each sinus cavity has a drainage pathway or outflow tract opening into the nasal passage. This drainage passageway can include an ostium, as well as a “transition space” in the region of the ostia, such as the “frontal recess,” in the case of the frontal sinus, or an “ethmoidal infundibulum,” in the case of the maxillary sinus. When the mucosa of one or more of the ostia or regions near the ostia become inflamed, the egress of mucous is interrupted, setting the stage for an infection and/or inflammation of the sinus cavity, i.e., sinusitis. Though many instances of sinusitis may be treatable with appropriate medicates, in some cases sinusitis persists for months or more, a condition called chronic sinusitis, and may not respond to medical therapy. Some patients are also prone to multiple episodes of sinusitis in a given period of time, a condition called recurrent sinusitis.


Balloon dilation has been applied to treat constricted sinus passageways for the treatment of sinusitis. These balloon dilation devices typically involve the use of an inflatable balloon located at the distal end of a catheter such as a balloon catheter. Generally, the inflatable balloon is inserted into the constricted sinus passageway in a deflated state. The balloon is then expanded to open or reduce the degree of constriction in the sinus passageway being treated to facilitate better sinus drainage and ventilation. At the same time most, if not all, of the functional mucosal tissue lining of the sinuses and their drainage passageways are preserved.


Exemplary devices and methods particularly suited for the dilation of anatomic structures associated with the maxillary and anterior ethmoid sinuses are disclosed, for example, in U.S. Pat. No. 7,520,876 and U.S. Patent Application Publication No. 2008-0172033. Other systems have been described for the treatment of various other sinuses including the frontal sinus. For example, U.S. Patent Application Publication No. 2008-0097295 discloses a frontal sinus guide catheter (FIG. 6B) and method of treating the frontal sinuses (e.g., FIGS. 8B-8C). U.S. Patent Application Publication No. 2008-0125626 discloses another guide device (e.g., FIGS. 10C and 10C′) for transnasal access to the frontal sinuses for treatment.


SUMMARY OF THE INVENTION

In a first embodiment of the invention, a balloon dilation catheter includes a substantially rigid inner guide member and a movable shaft coupled to a balloon that is slidably mounted on the substantially rigid inner guide member. To treat a drainage pathway of a sinus cavity (e.g., frontal sinus cavity) of a subject using the balloon dilation catheter, the substantially rigid inner guide member is advanced into a drainage pathway of the subject via a nasal passageway. The shaft and balloon are then advanced in a distal direction over the substantially rigid inner guide member to place the balloon in the drainage pathway. This enables the balloon to track over the inner guide member. The balloon is inflated to expand or otherwise remodel the drainage pathway. Where the sinus cavity is the frontal sinus cavity the drainage pathway is the frontal recess.


In another aspect of the invention, a device for dilating the outflow tract of a sinus cavity includes a substantially rigid inner guide member having a proximal end and a distal end and a shaft coupled to a balloon, the shaft having a first lumen along at least a portion thereof containing the substantially rigid inner guide member, the shaft having a second lumen operatively coupled to the interior of the balloon. A handle is disposed along a proximal portion of the substantially rigid inner guide member, the handle including a moveable knob operatively coupled to the shaft, wherein distal advancement of the knob advances the shaft and balloon over the substantially rigid inner guide in a distal direction.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a perspective view of a balloon dilation catheter according to one embodiment.



FIG. 2A illustrates a side view of a balloon dilation catheter of FIG. 1. The advancer knob is illustrated in the retracted, proximal position.



FIG. 2B illustrates a cross-sectional view of the balloon dilation catheter of FIG. 2A.



FIG. 3A illustrates a side view of a balloon dilation catheter of FIG. 1. The advancer knob is illustrated in the advanced, distal position.



FIG. 3B illustrates a cross-sectional view of the balloon dilation catheter of FIG. 3A.



FIG. 4 is a cross-sectional view of the handle portion (dashed line portion) of FIG. 3B.



FIG. 5A is a cross-sectional view of the balloon dilation catheter taken along the line A-A′ of FIG. 2B.



FIG. 5B is a cross-sectional view of the balloon dilation catheter taken along the line B-B′ of FIG. 4.



FIG. 6A is a side view of an inner guide member according to one embodiment.



FIG. 6B is a side view of an inner guide member according to another embodiment.



FIG. 6C is a side view of an inner guide member according to another embodiment.



FIG. 7 illustrates a perspective view of a balloon dilation catheter according to another embodiment.



FIG. 8 illustrates a cross-sectional view of the frontal sinus of a subject with the inner guide member of the balloon dilation catheter being advanced into the subject's frontal recess.



FIG. 9 illustrates a cross-sectional view of the frontal sinus of a subject with the inner guide member of the balloon dilation catheter being positioned in the subject's frontal recess. A guide wire is shown advanced through the catheter and into the subject's frontal sinus cavity.



FIG. 10 illustrates a cross-sectional view of the frontal sinus of a subject with the balloon (in a deflated state) and shaft being advanced into the subject's frontal recess.



FIG. 11 illustrates a cross-sectional view of the frontal sinus of a subject with the balloon of FIG. 10 in an inflated state to thereby widen and remodel the frontal recess.



FIG. 12 illustrates a cross-sectional view of the frontal sinus of a subject after the frontal sinus has been widened and the balloon inflation catheter withdrawn.





DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS


FIG. 1 illustrates one embodiment of a balloon dilation catheter 10 that is particularly suited for treatment of the outflow tract (frontal sinus ostium and frontal recess) of the frontal sinus of a subject. The balloon dilation catheter 10 includes a handle 12 that is configured to be gripped or otherwise manipulated by the operator. An elongate-shaped inner guide member 14 extends longitudinally from the handle 12 in a distal direction. The inner guide member 14 is formed of a suitably rigid material such as stainless steel hypotube. The inner guide member 14 projects or otherwise extends distally from the handle 12 for a pre-determined distance. The inner guide member 14 may be pre-shaped to have a curved distal portion 16 as is illustrated in FIGS. 1, 2A, 2B, 3A, 3B, 6A, 6B, 7, 8, and 9. For example, the nature and degree of the curved distal portion 16 may be configured to match with the frontal sinus outflow tract or frontal recess.


Alternatively, the inner guide member 14 may have some degree of malleability such that the user may bend or impart some desired shape or configuration to the distal end of the inner guide member 14. As explained herein in more detail, the inner guide member 14 may include an optional lumen 18 (best illustrated in FIG. 5A) that extends the length of the inner guide member 14. In particular, the inner guide member 14 and the contained lumen 18 may extend from a distal end 20 to a proximal end 21 (best seen in FIGS. 2B and 3B) that interfaces with a sealed arrangement with a port 22 disposed at a proximal end 24 of the handle 12. The port 22 may be configured with a conventional interface such as a Luer connector. The port 22 may be used as an aspiration port or a delivery port for fluids and/or medicaments, or for introduction of a guide wire.


Still referring to FIG. 1, a shaft 30 is mounted about the periphery of the inner guide member 14. In particular, the shaft 30 is dimensioned to slide over the inner guide member 14 in response to actuation of an advancer knob 32 located on the handle 12. The advancer knob 32 is moveable along a slot 42 contained in a surface of the handle 12. A distal end 34 of the shaft 30 includes a balloon 36 that is configured to be selectively inflated or deflated as explained herein. During use, the inner guide member 14 is manipulated and advanced across or into the anatomical space of interest. The shaft 30 as well as the attached balloon 36 is illustrated in a retracted state in FIG. 1. While FIG. 1 illustrates the balloon 36 in an inflated state for better illustration, the balloon 36 is typically in a deflated state when the shaft 30 is in the proximal position as illustrated in FIGS. 2A and 2B. After the inner guide member 14 is properly positioned, the user actuates the advancer knob 32 by sliding the same in the distal direction which, in turn, advances the shaft 30 and balloon 36 in a distal direction over the pre-placed inner guide member 14. Once the balloon 36 is properly placed, the balloon 36 is inflated. Inflation of the balloon 36 is accomplished using an inflation device (not shown) that is coupled to a port 38 located at the proximal end 24 of the handle 12. One exemplary inflation device that may be used in connection with the balloon dilation catheter 10 is described in U.S. Patent Application Publication No. 2010-0211007, which is incorporated by reference as if set forth fully herein. Of course, other inflation devices may also be used. An inflation lumen 48 contained within the shaft 30 (described in more detail below), fluidically couples the port 38 to an interior portion of the balloon 36.


Still referring to FIG. 1, an optional support member 40 in the form of a tube may be located about the external periphery of a portion of the shaft 30 to impart further stiffness to the balloon dilation catheter 10. The particular length of the support member 40 may vary depending on the application and may extend along some or all or the shaft 30. The support member 40 may be made of a metallic material such as stainless steel hypotube that is secured to the shaft 30. The support member 40 may be welded or bonded along a length of the shaft 30. Generally, the support member 40 does not cover the helical portion (described in detail below) of the shaft 30 that is contained within the handle 12.



FIGS. 2A and 2B illustrate, respectively, side and cross-sectional views of the balloon dilation catheter 10 with the advancer knob 32 and thus balloon 36 in the proximal position. In actual use, as explained herein, the balloon 36 is typically in a deflated state when the advancer knob 32 is the proximal position as illustrated in FIGS. 2A and 2B. As best seen in FIG. 1, the advancer knob 32 is slidably disposed along a length of the handle 12 inside a slot 42. The advancer knob 32 is thus able to slide back and forth in the distal/proximal direction along the length of the slot 42. The slot 42 may incorporate a stop or the like (not shown) to prevent the balloon 36 from being advance too far along the length of the inner guide member 14. The length of the slot 42 may be varied in different devices to adjust the length at which the balloon 36 may be advanced. Generally, the slot 42 has a length within the range of about 1 inch to about 2 inches although other dimensions may fall within the scope of the invention.


As seen in FIG. 2B, the advancer knob 32 may be directly coupled to the support member 40 that is mounted on the shaft 30. Alternatively, the advancer knob 32 may be coupled directly to the shaft 30. The advancer knob 32 may be configured or otherwise shaped to enable a finger of the user (e.g., index finger or thumb) to easily advance or retract the knob 32 along the slot 42 contained in the handle 12.



FIGS. 3A and 3B illustrate, respectively, side and cross-sectional views of the balloon dilation catheter 10 with the advancer knob 32 and thus balloon 36 in the distal position. Thus, unlike the configurations of FIGS. 2A and 2B, the advancer knob 32 is located at or near the distal end 26 of the handle 12. Advancement of the advancer knob 32 also slides the shaft 30 and attached balloon 36 in a distal direction (arrow A in FIG. 3A) along the inner guide member 14. The balloon 36 thus is positioned at or adjacent to the distal end 20 of the inner guide member 14. The balloon dilation catheter 10 may be designed such that the advancer knob 32 may be positioned at either the proximal or distal extremes as illustrated in FIGS. 2A, 2B, 3A, 3B. Alternatively, the advancer knob 32 may be positioned somewhere in between the two extremes. For example, the optimal position of the balloon 36 may be accomplished by sliding the advancer knob 32 some fraction (e.g., ¾) of the full distance of the slot 42.


Referring to FIGS. 2B and 3B, the inner guide member 14 of the balloon dilation catheter 10 extends from a distal end 20 to a proximal end 21 that terminates in a sealed interface with a port 22 disposed at a proximal end 24 of the handle 12. The inner guide member 14 optionally includes a lumen 18 disposed therein that may be used to provide aspiration functionality via an aspiration device (not shown) coupled to port 22. Aspiration functionality permits the removal of blood and other secretions. This makes it easier to visualize the placement of the balloon dilation catheter 10. The inner guide member 14 is advantageously rigid to enable the balloon dilation catheter 10 to be positioned without the need of a separate guiding catheter or guide wire in most, if not all, instances.


The inner guide member 14 may have a length of about 7 inches to about 11 inches from the distal end 20 to the proximal end 21 when loaded into the handle 12, although other dimensions may be used. The inner guide member 14 may be formed from stainless steel hypotube having an inner diameter in the range of about 0.020 inch to about 0.050 inch, and more preferably between about 0.036 inch and 0.040 inch, with a wall thickness within the range of about 0.005 inch to about 0.020 inch, and more preferably between about 0.008 inch to about 0.012 inch. The curved distal portion 16 of the inner guide member 14 may be formed right to the distal end 20 and may have a radius of curvature of about 0.25 inch to about 1.5 inch, and more preferably about 0.75 to about 1.25 inch.


The length of the inner guide member 14 that projects distally from the distal-most portion of the balloon 36 is about 0.5 inch to about 2.0 inch, and more preferably, about 0.8 inch to about 1.2 inch when the balloon 36 is in the fully retracted state (e.g., illustrated in FIGS. 2A and 2B). As seen in FIGS. 1, 2A, 2B, 3A, 3B, 6A-6C, 7-11, the distal end 20 of the inner guide member 14 may incorporate an optional bulbous tip 44 in order to make the distal end 20 more atraumatic. The bulbous tip 44 further serves to limit forward movement of the balloon 36 and attached shaft 30 when they are advanced distally. The outer diameter of the tip 44 is preferably between about 1 mm and about 3 mm.


The balloon 36 is mounted on the shaft 30 so as to form a fluidic seal between the two components. The balloon 36 may be bonded to the shaft using a weld, adhesive, or the like. Alternately, the balloon 36 may be secured to the shaft using a mechanical connection. Generally, any technique known to those skilled in the art may be used to secure to the balloon 36 to the shaft 30. Given that the balloon 36 is secured directly to the shaft 30, both structures are slidably mounted over the inner guide member 14. The balloon 36 generally takes on a cylindrical-shape when inflated. While not limited to specific dimensions, the inflated balloon 36 has a diameter within the range of about 3 mm to about 9 mm, and more preferably a diameter within the range of about 5 to about 7 mm when inflated. The length of the balloon 36 may generally fall within the range of about 10 mm to 25 mm although other lengths may be used. Both the shaft 30 and the balloon 36 are preferably formed of high strength but flexible polymeric materials such as polyamides (e.g., Nylon), PEBAX or the like. The balloon 36 may be “blow molded” to a relatively thin wall thickness, and capable of holding relatively high pressures from about 6 atmospheres to about 20 atmospheres of inflation pressure. The balloon 36 is inflated using a fluid which is typically a liquid such as water or saline.


Referring now to FIG. 4, a magnified, cross-sectional view of a portion of the handle 12 is illustrated. At the proximal end 24 of the handle 12 are located ports 22, 38. The port 22 may be configured with a conventional interface such as a Luer connector or any other connector known to those skilled in the art. The port 22 may be integrally formed with the handle 12 or, alternatively, the port 22 may be a separate structure that is secured to the handle 12 during assembly. As seen in FIG. 4, the proximal end 21 of the inner guide member 14 forms a sealing arrangement with the port 22. As explained herein, the port 22 may be used as an aspiration port or a delivery port for fluids and/or medicaments.



FIG. 4 also illustrates port 38 which may be constructed in the same or similar manner as port 22 as described above. The port 38 is fluidically coupled to the inflation lumen 48 in the shaft 30. In this regard, inflation fluid from an inflation device (not shown) is able to pass through the port 38 and into the inflation lumen 48 of the shaft 30. The port 38 may be configured with a conventional interface such as a Luer connector. The fluid then is able to travel along the length of the shaft 30 via the lumen 48 where the fluid enters the interior of the balloon 36. The inflation fluid is thus able to inflate the balloon 36 upon actuation of the inflation device.


As best seen in FIG. 4, a portion of the handle 12 includes a recessed region 50 that receives both the inner guide member 14 and the shaft 30. In the recessed region 50 of the handle 12, the shaft 30 is helically wrapped around the outer periphery of the inner guide member 14 forming a helical portion 52. The helical portion 52 facilitates the distal advancement and proximal retraction of the shaft 30 and attached balloon 36 along the inner guide member 14 yet still maintains fluid communication with the port 38. The helical portion 52 of the shaft 30, which is located proximal to the advancer knob 32 is in the shape of a helix that wraps around the inner guide member 14 and is configured to elongate and contract upon movement of the advancer knob 32. FIG. 4 illustrates the state of the helical portion 52 after the advancer knob 32 has been advanced distally. Thus, in the extended state, the length of the helical portion 52 traverses much if not all of the recessed region 50. Contrast this with FIG. 2B which illustrates the helical portion 52 compressed to the proximal portion of the recessed region 50 because the advancer knob 32 is the in proximal position. Thus, the helical portion 52 is thus able to expand or compress much in the way that a spring does in response to a tensile or compressive load. One or both of the inner guide member 14 and the helical portion 52 of the shaft 30 may be optionally coated or lined with a lubricious coating to prevent the contact surfaces from any unwanted frictional binding or the like.


The helical portion 52 of the shaft 30 may be formed by “skiving” away a portion of the shaft 30. FIG. 5A illustrates a cross-sectional view of the shaft 30, inner support guide 14, and support member 40 along the line A-A′ of FIG. 2B. As seen in FIG. 2B, this area is distal to where the helical portion 52 of the shaft 30 is located. Referring now to FIG. 5A, the shaft 30 includes a rider lumen 54 that is dimensioned to have a diameter that is slightly larger than the outer diameter of the inner support guide 14. The rider lumen 54 thus enables the shaft 30 to advance and retract over the inner support guide 14 in a close-fit arrangement. The outer diameter of the shaft 30 may generally fall within the range of about 0.050 inch to about 0.110 inch or within the range of about 0.070 inch to about 0.100 inch. One or both of the exterior surface of the inner guide member 14 and the interior surface of the rider lumen 54 may be optionally coated with a lubricious coating to reduce frictional contact forces. FIG. 5B illustrates a cross-sectional view of the inner support guide 14 and the helical portion 52 of the shaft 30 taken along the line B-B′ of FIG. 4. As seen in FIG. 5B, a portion of the shaft 30 that includes the rider lumen 54 is skived away. The result is that a single lumen (inflation lumen 48) remains in the shaft 30 that is helically wrapped about the inner support guide 14.



FIGS. 6A-6C illustrate various embodiments of an inner guide member 14. The inner guide member 14 may have a variety of shapes and configurations depending on the particular application or patient. The different shapes of the inner guide member 14 may be factory-formed in a particular shape and offered as a different model as fully assembled or, alternatively, the inner guide member 14 may be replaceable or modular elements that could slide inside the rider lumen 54 and inserted into the port 22 in a press-fit type sealing arrangement. In yet another alternative, the shapes could represent desirable shapes that a malleable inner guide member 14 could be formed into by the user to better fit a particular application or subject's anatomy.



FIG. 6A illustrates an inner guide member 14 that includes a curved distal portion 16 that terminates in a straight segment 46. In the embodiment of FIG. 6A, the curve in the curved distal portion 16 is pronounced and turns back on itself in the shape of a “U” in which the distal end 20 turns back in retrograde fashion. This embodiment may be useful to treat hard to reach ostia or other structures, e.g., the maxillary ostium or the infundibulum via a transnasal route, if the nasal anatomy will allow for a transnasal approach. While FIG. 6A illustrates a “U” shaped curve, other degrees of curvature are contemplated. FIG. 6B illustrates an inner guide member 14 according to another embodiment. In this embodiment, the curved distal portion 16 also terminates in a straight segment 46 although the radius of curvature is less pronounced. In this embodiment, the straight segment 46 may have a length within the range of about 8 mm to about 10 mm although other lengths may be used. It is believed that this embodiment is particularly suited for most frontal recess anatomy. FIG. 6C illustrates an embodiment in which the inner guide member 14 is substantially straight. This later embodiment may be particularly suited for treating the sphenoids of the subject, or straightforward frontal recess anatomy.



FIG. 7 illustrates a balloon dilation catheter 10 according to another embodiment. In this embodiment, a tracking element 60 is located on the handle 12 of the balloon dilation catheter 10. The tracking element 60 may include an antenna, transmitter, optical reflectors, or the like that communicates a wireless signal that is then received and processed to determine the orientation and/or positioning of the balloon dilation catheter 10. In certain embodiments, more than one tracking element 60 may be disposed on the balloon dilation catheter 10. Data regarding the orientation and/or positioning of the balloon dilation catheter 10 may then be processed and displayed on the display for viewing by the physician. For example, image guided surgery is becoming increasingly commonplace, permitting physicians to review real time actual or virtual images of a particular device within a subject during a surgical procedure.


For example, U.S. Pat. Nos. 5,391,199 and 5,443,489, which are incorporated by reference, describe a system wherein coordinates of an intrabody probe are determined using one or more field sensors such as, Hall effect devices, coils, or antennas that are carried on the probe. U.S. Patent Application Publication No. 2002-0065455, which is also incorporated by reference, describes a system that is capable of generating a six-dimensional position and orientation representation of the tip of a catheter using a combination of sensor and radiation coils. U.S. Patent Application Publication No. 2008-0269596, which is also incorporated by reference, describes yet another monitoring system that has particular applications in orthopedic procedures. Commercial systems such as the LANDMARX Element (Medtronic Xomed Products, Inc., Jacksonville, Fla.) are available for use in conjunction with ENT procedures.


In the embodiment of FIG. 7, the tracking element 60 permits accurate tracking of the distal end 20 of the balloon dilation catheter 10 such that an image of distal portion of the balloon dilation catheter 10 may be superimposed on a patient's anatomical imagery. For example, a previously conducted computed tomography (CT) scan of the patient may be used to generate a visual image of the patient's anatomical regions of interest. Based on the location of the tracking element 60, an image guided surgery (IGS) system can then superimpose an image of the balloon dilation catheter 10 onto the image to better enable the physician to manipulate and orient the balloon dilation catheter 10.


Other commercial systems may also be used in connection with the balloon dilation catheter 10 illustrated in FIG. 7. For example, the INSTATRAK 3500 Plus-ENT from GE Healthcare, Chalfont St. Giles, United Kingdom may be integrated and/or used with the balloon dilation catheter 10. The use of CT guidance to position the balloon dilation catheter 10 is preferred because the device may be positioned by the operator with just a single hand, while viewing the CT image interface (e.g., display) at the same time the handle 12 is manipulated. Optionally, the balloon dilation catheter 10 may be initially positioned using and endoscope or other visualization tool. For instance, a conventional “Hopkins rod” endoscope (not shown) may be manipulated alongside the balloon dilation catheter 10 to aid in placement.



FIGS. 8-12 illustrate various cross-sectional views (sagittal plane) of the frontal sinus of a subject undergoing treatment with a balloon dilation catheter 10. The cross-sectional views illustrate the nasal passageway 100, the frontal recess 102, and the frontal sinus cavity 104. Referring to FIG. 8, the balloon dilation catheter 10 is inserted into the nasal passageway 100 with the advancer knob 32 in the retracted position (e.g., as illustrated in FIG. 1, 2A, 2B) such that the shaft 30 and balloon 36 are also retracted proximally. In addition, the balloon 36 is in a deflated state as seen in FIG. 8. The curved portion 16 of the inner guide member 14 is then positioned within the frontal recess 102 of the subject as seen in FIG. 8. This positioning of the inner guide member 14 may be accomplished under endoscopic visualization using a conventional endoscope such as a Hopkins rod-type endoscope that is positioned alongside the balloon dilation catheter 10. Alternatively, the inner guide member 14 may be positioned using IGS techniques that track the position of the balloon dilation catheter 10 using one or more tracking elements 60 as illustrated, for instance, in the embodiment of FIG. 7. For instance, the inner guide member 14 may be advanced under guidance from CT imaging.


Referring now to FIG. 9, confirmation of accurate positioning of the inner guide member 14 within the frontal recess 102 may be accomplished by placement of a fluoroscopically visible guide wire 64 through the lumen 18 of the inner guide member 14. The guide wire 64 may be inserted into the lumen 18 via the port 22. Under fluoroscopic visualization, the guide wire 64 can be seen to advance into the frontal sinus cavity 104 once the inner guide member 14 is positioned properly within the frontal recess 102. If the guide wire 64 does not advance into the frontal sinus cavity 104, the balloon dilation catheter 10 is re-positioned and confirmation is subsequently attempted. As an alternative to a fluoroscopically visible guide wire 64, the guide wire 64 could be a light emitting guide wire such as that disclosed in U.S. Patent Application Publication No. 2007-0249896, which is incorporated by reference herein. Of course, the guide wire 64 is optional as the inner guide member 14 may be placed without the aid or need for the same. Alternatively, the guide wire 64 could be positioned in the frontal sinus initially, prior to placement of the balloon catheter 10.


Now referring to FIG. 10, once the curved portion 16 of the inner guide member 14 is properly positioned, the advancer knob 32 is advanced in the distal direction (arrow A of FIG. 3A) thereby advancing the shaft 30 and attached balloon 36 into the frontal recess 102. This is illustrated in FIG. 10. After the balloon 36 is positioned in the frontal recess 102, the balloon 36 is inflated as illustrated in FIG. 11. Inflation is accomplished by coupling an inflation device (not shown) to the port 38. The inflation device may include a syringe or the like that is depressed to infuse a fluid into the inflation lumen 48 which then passes into the interior of the balloon 36 to effectuate expansion of the balloon 36 to the state illustrated in FIG. 11. Pressures typically used to accomplish widening or remodeling of the frontal recess 102 are within the range of about 3 atmospheres to about 12 atmospheres. The balloon 36 may be inflated only a single time or, alternatively, the balloon 36 may be inflated, deflated, and inflated again a plurality of times in order to achieve the desired degree of widening. Each inflation step may be performed after positioning the balloon 36 in a different position within the frontal recess 102.


After the frontal recess 102 has been widened or otherwise remodeled, the balloon 36 is deflated and removed as illustrated in FIG. 12. The widened frontal recess 102 illustrated in FIG. 12 is believed to restore the drainage and aeration function and health of the frontal sinus cavity 104. Deflation of the balloon 36 is accomplished by reducing the fluid pressure within the interior of the balloon 36. For example, the plunger of a syringe or the like that is fluidically coupled to the port 38 may be withdrawn to remove fluid from the interior of the balloon 36. The balloon dilation catheter 10 can then be withdrawn proximally from the nasal passageway 100.


In certain patients, treatment of one or both frontal sinuses 104 as described above may be adequate. In other patients, additional sinuses may need to be treated, particularly the maxillary and/or anterior ethmoid sinuses. In such patients, a combination procedure may be well suited. The maxillary and/or anterior ethmoid sinuses can be treated with a system such as described in U.S. Pat. No. 7,520,876 and U.S. Patent Application Publication No. 2008-0172033, commercially available as the FinESS system by Entellus Medical, Inc. of Maple Grove, Minn. Alternatively, other sinuses could be treated more conventionally using surgical techniques such as, for instance, functional endoscopic sinus surgery (FESS).


Also, the sphenoid and/or maxillary sinus outflow tracts could be dilated with the embodiment of the balloon catheter 10 described above. It is also contemplated that the balloon catheter 10, particularly the embodiment of FIG. 7 with a suitable IGS device is incorporated, and with an appropriate shape for the inner support member 14, preferably straight as illustrated in FIG. 6C, could be used to dilate the maxillary sinus outflow tract via the canine fossa route. Suitable access tools are described in co-pending U.S. Patent Application Publication No. 2009-0216196, which is incorporated by reference herein. This could be performed without need for additional endoscopic visualization, permitting treatment through a relatively small diameter access passageway into the sinus cavity in the region of the canine fossa. A small endoscope (not shown) could be utilized, if desired, through the lumen 18 of the inner support member 14 to further aid in visualization of the maxillary sinus outflow tract.


While embodiments of the present invention have been shown and described, various modifications may be made without departing from the scope of the present invention. The invention, therefore, should not be limited, except to the following claims, and their equivalents.

Claims
  • 1. A balloon dilation catheter for use in a sinus or sinus drainage pathway comprising: a handle configured to be gripped by an operator;an inner guide member extending longitudinally from the handle in a distal direction, the inner guide member formed from a substantially rigid metallic hypotube defining a first lumen, the substantially rigid metallic hypotube having a blunt distal end and a proximal end secured within the handle;a shaft slidably arranged over the inner guide member, wherein a distal portion of the shaft includes an inflatable balloon;a moveable shaft advancing member disposed in the handle and coupled to the shaft, the moveable shaft advancing member configured to be manipulated by a thumb of an operator of the balloon dilation catheter to advance the shaft over the inner guide member from a retracted state to an extended state; andwherein a length of the inner guide member projects distally from a distal-most portion of the inflatable balloon within the range of about 0.5 inch to about 2.0 inch in the retracted state.
  • 2. The balloon dilation catheter of claim 1, wherein the shaft defines a rider lumen and the inner guide member extends through the rider lumen when the shaft is in a fully retracted position.
  • 3. The balloon dilation catheter of claim 1, wherein the handle defines a slot extending along a longitudinal length of the handle and wherein the moveable shaft advancing member is configured to translate along the slot.
  • 4. The balloon dilation catheter of claim 1, wherein a distal portion of the inner guide member is malleable and can be shaped by the operator into a desired configuration and maintain the desired configuration while the shaft and inflatable balloon are advanced over the inner guide member.
  • 5. The balloon dilation catheter of claim 1, wherein the inner guide member has an inner diameter in the range of 0.020 and 0.050 inches.
  • 6. The balloon dilation catheter of claim 5, wherein the inner guide member has an inner diameter in the range of 0.036 and 0.040 inches.
  • 7. The balloon dilation catheter of claim 1, wherein the inner guide member has a wall thickness in the range of 0.005 and 0.020 inches.
  • 8. The balloon dilation catheter of claim 7, wherein the inner guide member has a wall thickness in the range of 0.008 and 0.012 inches.
  • 9. The balloon dilation catheter of claim 1, wherein the inner guide member includes a curved distal end, wherein the radius of curvature of the curved distal end is between 0.25 and 1.5 inches.
  • 10. The balloon dilation catheter of claim 9, wherein the inner guide member includes a curved distal end, wherein the radius of curvature of the curved distal end is between 0.75 and 1.25 inches.
  • 11. The balloon dilation catheter of claim 1, wherein the blunt distal end of the inner guide member has a diameter of between 1 and 3 millimeters.
  • 12. The balloon dilation catheter of claim 1, further including a tracking element disposed in the handle for use with an image guided surgery system.
  • 13. The balloon dilation catheter of claim 1, wherein a flexible guide wire is disposed within the first lumen of the inner guide member.
RELATED APPLICATIONS

This Application is a continuation of U.S. patent application Ser. No. 14/524,889, filed on Oct. 27, 2014, now issued as U.S. Pat. No. 9,339,637, which itself is a continuation of U.S. application Ser. No. 13/644,538, filed on Oct. 4, 2012, now U.S. Pat. No. 8,882,795, which is a continuation of U.S. patent application Ser. No. 13/116,712 filed on May 26, 2011, which is a continuation of U.S. application Ser. No. 12/479,521, filed on Jun. 5, 2009, now U.S. Pat. No. 8,282,667. The above-noted Applications are incorporated by reference as if set forth fully herein.

US Referenced Citations (185)
Number Name Date Kind
2525183 Robison Oct 1950 A
3800788 White Apr 1974 A
3861393 Durand Jan 1975 A
4737141 Spits Apr 1988 A
5024658 Kozlov et al. Jun 1991 A
5021043 Becker et al. Jul 1991 A
5169386 Becker et al. Dec 1992 A
5195989 Euteneuer Mar 1993 A
5324257 Osborne Jun 1994 A
5391199 Ben-Haim Feb 1995 A
5415634 Glynn et al. May 1995 A
5441497 Narciso, Jr. Aug 1995 A
5443489 Ben-Haim Aug 1995 A
5466222 Ressemann et al. Nov 1995 A
5470315 Adams Nov 1995 A
5569274 Rapacki et al. Oct 1996 A
5588950 Sano et al. Dec 1996 A
5632762 Myler May 1997 A
5645628 Thome Jul 1997 A
5795325 Valley et al. Aug 1998 A
5964767 Tapia et al. Oct 1999 A
6083188 Becker Jul 2000 A
6090132 Fox Jul 2000 A
6113567 Becker Sep 2000 A
6206870 Kanner Mar 2001 B1
6238364 Becker May 2001 B1
6491940 Levin Dec 2002 B1
6543452 Lavigne Apr 2003 B1
D501677 Becker Feb 2005 S
6851424 Scopton Feb 2005 B2
7500971 Chang et al. Mar 2009 B2
7520876 Ressemann et al. Apr 2009 B2
7678099 Ressemann et al. Mar 2010 B2
7785315 Muni et al. Aug 2010 B1
7842062 Keith et al. Nov 2010 B2
7879061 Keith et al. Feb 2011 B2
7918871 Truitt et al. Apr 2011 B2
8114113 Becker Feb 2012 B2
8146400 Goldfarb et al. Apr 2012 B2
8241266 Keith et al. Aug 2012 B2
8277478 Drontle et al. Oct 2012 B2
8282667 Drontle et al. Oct 2012 B2
8348969 Keith et al. Jan 2013 B2
8568439 Keith et al. Oct 2013 B2
8585728 Keith et al. Nov 2013 B2
8585729 Keith et al. Nov 2013 B2
8623043 Keith et al. Jan 2014 B1
8657846 Keith et al. Feb 2014 B2
8801670 Drontle et al. Aug 2014 B2
8834513 Hanson et al. Sep 2014 B2
8882795 Drontle et al. Nov 2014 B2
8888686 Drontle et al. Nov 2014 B2
8915938 Keith et al. Dec 2014 B2
8986340 Drontle et al. Mar 2015 B2
9005284 Ressemann Apr 2015 B2
9011412 Albritton, IV et al. Apr 2015 B2
9101739 Lesch, Jr. et al. Aug 2015 B2
9192748 Ressemann et al. Nov 2015 B2
9278199 Keith et al. Mar 2016 B2
9282986 Hanson Mar 2016 B2
9283360 Lesch et al. Mar 2016 B2
9320876 Ressemann et al. Apr 2016 B2
9333327 Setliff, III et al. May 2016 B2
9339637 Drontle et al. May 2016 B2
9370650 Hanson Jun 2016 B2
9433343 Drontle et al. Sep 2016 B2
9440049 Drontle et al. Sep 2016 B2
9486614 Drontle et al. Nov 2016 B2
9550049 Hanson et al. Jan 2017 B2
9694167 Keith et al. Jul 2017 B2
9700705 Lesch, Jr. et al. Jul 2017 B2
9775975 Ressemann et al. Oct 2017 B2
10022525 Hanson et al. Jul 2018 B2
10029069 Keith et al. Jul 2018 B2
10086181 Lesch et al. Oct 2018 B2
20020065455 Ben-Haim et al. May 2002 A1
20020138121 Fox Sep 2002 A1
20040064083 Becker Apr 2004 A1
20040064150 Becker Apr 2004 A1
20040068299 Laske et al. Apr 2004 A1
20050059931 Garrison et al. Mar 2005 A1
20050075661 Levine et al. Apr 2005 A1
20050240147 Makower et al. Oct 2005 A1
20050245906 Makower et al. Nov 2005 A1
20050251119 Eaton et al. Nov 2005 A1
20060004286 Chang et al. Jan 2006 A1
20060004323 Chang et al. Jan 2006 A1
20060063973 Makower et al. Mar 2006 A1
20060095066 Chang et al. May 2006 A1
20060100687 Fahey et al. May 2006 A1
20060106361 Muni et al. May 2006 A1
20060111691 Bolmsjo et al. May 2006 A1
20060149310 Becker Jul 2006 A1
20060210605 Chang et al. Sep 2006 A1
20060284428 Beadle et al. Dec 2006 A1
20060293612 Jenson et al. Dec 2006 A1
20070005094 Eaton et al. Jan 2007 A1
20070073269 Becker Mar 2007 A1
20070129751 Muni et al. Jun 2007 A1
20070135789 Chang et al. Jun 2007 A1
20070135803 Belson Jun 2007 A1
20070167682 Goldfarb et al. Jul 2007 A1
20070208252 Makower Sep 2007 A1
20070208301 Evard et al. Sep 2007 A1
20070249896 Goldfarb et al. Oct 2007 A1
20070250105 Ressemann et al. Oct 2007 A1
20070270644 Goldfarb et al. Nov 2007 A1
20070282305 Goldfarb et al. Dec 2007 A1
20070293726 Goldfarb et al. Dec 2007 A1
20070293727 Goldfarb et al. Dec 2007 A1
20080015472 Ressemann et al. Jan 2008 A1
20080015540 Muni et al. Jan 2008 A1
20080033353 Truitt et al. Feb 2008 A1
20080082045 Goldfarb Apr 2008 A1
20080097154 Makower et al. Apr 2008 A1
20080097239 Chang et al. Apr 2008 A1
20080097295 Makower et al. Apr 2008 A1
20080097400 Chang et al. Apr 2008 A1
20080097514 Chang et al. Apr 2008 A1
20080097515 Chang et al. Apr 2008 A1
20080097516 Chang et al. Apr 2008 A1
20080103521 Makower et al. May 2008 A1
20080119693 Makower et al. May 2008 A1
20080125626 Chang et al. May 2008 A1
20080132938 Chang et al. Jun 2008 A1
20080154217 Carrez et al. Jun 2008 A1
20080154237 Chang et al. Jun 2008 A1
20080154250 Makower et al. Jun 2008 A1
20080172033 Keith et al. Jul 2008 A1
20080195041 Goldfarb et al. Aug 2008 A1
20080228085 Jenkins et al. Sep 2008 A1
20080234720 Chang et al. Sep 2008 A1
20080269596 Revie et al. Oct 2008 A1
20080275483 Makower et al. Nov 2008 A1
20080281156 Makower et al. Nov 2008 A1
20080287908 Muni Nov 2008 A1
20080319424 Muni et al. Dec 2008 A1
20090005763 Makower et al. Jan 2009 A1
20090028923 Muni et al. Jan 2009 A1
20090030274 Goldfarb et al. Jan 2009 A1
20090030380 Binmoeller Jan 2009 A1
20090073718 Chung Mar 2009 A1
20090093823 Chang et al. Apr 2009 A1
20090132033 Maurer et al. May 2009 A1
20090187098 Makower et al. Jul 2009 A1
20090198216 Muni et al. Aug 2009 A1
20090204142 Becker Aug 2009 A1
20090216196 Drontle et al. Aug 2009 A1
20090318875 Friedman Dec 2009 A1
20100016811 Smith Jan 2010 A1
20100030113 Morriss et al. Feb 2010 A1
20100168511 Muni et al. Jul 2010 A1
20100211007 Lesch et al. Aug 2010 A1
20100241155 Chang et al. Sep 2010 A1
20100274222 Setliff, III et al. Oct 2010 A1
20100312101 Drontle Dec 2010 A1
20110071349 Drontle et al. Mar 2011 A1
20110224652 Drontle et al. Sep 2011 A1
20120010646 Keith et al. Jan 2012 A1
20120184983 Chang et al. Jul 2012 A1
20120283625 Keith et al. Nov 2012 A1
20130030458 Drontle et al. Jan 2013 A1
20130030459 Drontle et al. Jan 2013 A1
20130041463 Ressemann Feb 2013 A1
20130072958 Ressemann et al. Mar 2013 A1
20130123833 Lesch et al. May 2013 A1
20140350520 Drontle et al. Nov 2014 A1
20140357959 Hanson et al. Dec 2014 A1
20140364700 Hanson et al. Dec 2014 A1
20140378776 Hanson et al. Dec 2014 A1
20150031950 Drontle et al. Jan 2015 A1
20150105818 Keith et al. Apr 2015 A1
20160038726 Hanson et al. Feb 2016 A1
20160151614 Ressemann et al. Jun 2016 A1
20160166814 Lesch et al. Jun 2016 A1
20160367286 Drontle et al. Dec 2016 A1
20160375229 Setfliff, III et al. Dec 2016 A1
20170007282 Drontle Jan 2017 A1
20170028112 Drontle et al. Feb 2017 A1
20170050001 Drontle et al. Feb 2017 A1
20170113027 Drontle et al. Apr 2017 A1
20170368319 Lesch, Jr. et al. Dec 2017 A1
20180008806 Ressemann et al. Jan 2018 A1
20180304051 Keith et al. Oct 2018 A1
20180304058 Hanson et al. Oct 2018 A1
Foreign Referenced Citations (12)
Number Date Country
0 129 634 Jan 1985 EP
159815 Nov 2005 EP
2009-505691 Feb 2009 JP
WO 91177787 Nov 1991 WO
WO 9600033 Jan 1996 WO
WO9600033 Jan 1996 WO
WO 2005086945 Sep 2005 WO
WO 2007035204 Mar 2007 WO
WO 2009065085 May 2009 WO
WO2010014799 Feb 2010 WO
2017135980 Aug 2017 WO
2017192394 Nov 2017 WO
Non-Patent Literature Citations (49)
Entry
Iro, H., J. Zenk, “A new device for frontal sinus endoscopy: First Clinical Report”, Department of Otorhinolaryngology, University of Eralngen-Nuremberg, Germany. Otorhinolaryngology, Head and Neck Surgery vol. 125 No. 6, Dec. 2001, pp. 613-616 (4 pages).
Petersen, Robert J., Canine Fossa Puncture, The Laryngoscope Office, Oct. 5, 1972, pp. 369-371.
Elidan, J., MD., Irrigation of the Maxillary Sinus by Canine Fossa Puncture Experience with 202 Patients, Ann Otol Rhinol Laryngol, 92:1983, pp. 528-529.
Yanagisawa, Eiji, et al., Trans-Canine-Fossa Maxillary Sinoscopy for Biopsy Via the Stammberger Technique, ENT Rhinoscopic Clinic, Aug. 2001 Rhino, pp. 1-3.
Yanagisawa, Eiji, et al., Powered Endoscopic Inferior Meatal Antrostomy Under Canine Fossa Telescopic Guidance, ENT-Ear, Nose & Throat Journal, Sep. 2001, pp. 618-620.
Sathananthar, Shanmugam, et al., Canine Fossa Puncture and Clearance of the Maxillary Sinus for the Severely Diseased Maxillary Sinus, The Laryngoscope 115: Jun. 2005, pp. 1026-1029.
Robinson, Simon, et al., Patterns of Innervation of the Anterior Maxilla: A Cadaver Study with Relevance to Canine Fossa Puncture of the Maxillary Sinus, Laryngoscope 115: Oct. 2005, pp. 1785-1788.
Bolger, William, E., et al., Catheter-Based Dilation of the Sinus Ostia: Initial Safety and Feasibility Analysis in a Cadaver Model, Maryland Sinus Clinic, Bethesda, Maryland, and California Sinus Institute, Palo Alto, California, OceanSide Publications, Inc., May-Jun. 2006, vol. 20, No. 3, pp. 290-294.
Friedman, Michael, M.D. et al., Functional Endoscopic Dilatation of the Sinuses (FEDS): Patient Selection and Surgical Technique, Operative Technologies in Otolaryngology, vol. 17, No. 2, Jun. 2006, pp. 126-134.
Jones, Nick, Commentary on “Safety and Feasibility of Balloon Catheter Dilation of Paranasal Sinus Ostia: A Preliminary Investigation”, Annals of Otology, Rhinology & Laryngology 115(4), pp. 300-301 (2006).
Bolger, William E., Commentary Misconceptions Regarding Balloon Catheter Dilation of Paranasal Sinus Ostia, Annals of Otology, Rhinology & Laryngology 115(10): 791-792 (2006).
Lanza, Donald, C., et al., Commentary Balloon Sinuplasty: Not Ready for Prime Time, Annals of Otology, Rhinology & Laryngology 115(10): 789-790 (2006).
Brown, Christopher, L., et al., “Safety and Feasibility of Balloon Catheter Dilation of Paranasal Sinus Ostia: A Preliminary Investigation”, Annals of Otology, Rhinology & Laryngology 115(4):293-299 (2006).
Gottman, D., et al., “Balloon Dilatation of Recurrent Ostia Occlusion of the Frontal Sinus”, ECR Mar. 3, 2001, 2:-3:30 PM, Vienna Austria (1 page).
Entellus Medical, 510(k) Premarket Notification cover letter and Attachment B: Predicate Device Labeling, dated Aug. 15, 2007.
R. Peterson, Sinus Puncture Therreapy: Canine Fossa Puncture Method “How I Do It” Head and Neck, The Larynsgoscope 91: Dec. 1981, pp. 2126-2128.
T.G.A. Ijaduola, Use of a Foley Catheter for Short-Tem Drainage of Frontal Sinus Surgery, Journ. of Laryngology and Otology, Apr. 1989, vol. 103, pp. 375-378.
A. Gatot et al., Early Treatment of Oribital Floor Fractures with Catheter Balloon in Childre, Int'l. J. of Ped. Otorhinolaryngology, 21 (1991) 97-101.
D.I. Tarasov et al., Treatment of Chronic Ethmoiditis by IntraCellular Administration of Medicines to the Ethmoidal Labyrinth, Vestn Otorinolaringol. Nov.-Dec. 1978; (6):45-47 (Abstract in English).
J.M. Robison, Pressure Treatment of Maxillary Sinusitis, J.A.M.A., May 31, 1952, pp. 436-440.
J.M. Robison, Pressure Treatment of Purulent Maxillary Sinusitis, Texas State Journal of Medicine, May 1952, pp. 281-288.
Entellus Medical, 510(k) Letter (Amendment 1) and Attachment D&E, dated Mar. 13, 2008.
Gottman et al., Balloon Dilation of Recurrent Ostial Occlusion of the Frontal Sinus, Gottman et al.: Abstract (B-0453) Mar. 2001, 22 pages.
PCT International Search Report for PCT/US2007/088834, Applicant: Entellus Medical, Inc., Forms PCT/ISA/220 and PCT/ISA/210, dated May 20, 2008 (4 pages).
PCT Written Opinion for PCT/US2007/088834, Applicant: Entellus Medical, Inc., Forms PCT/ISA/237, dated May 20, 2008 (10 pages).
PCT International Search Report for PCT/US2007/66187, Applicant: Entellus Medical, Inc., Forms PCT/ISA/220 and PCT/ISA/210, dated Apr. 17, 2008 (5 pages).
PCT Written Opinion for PCT/US2007/66187, Applicant: Entellus Medical, Inc., Forms PCT/ISA/237, dated Apr. 17, 2008 (5 pages).
Folweiler, David S., Nasal Specific Technique as Part of a Chropractic Approach to Chronic Sinusitis and Sinus Headaches, Journal of Manipulative and Physiological Therapeutics, vol. 18, No. 1 (Jan. 1995).
PCT International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty) of the International Bureau for PCT/US2007/066187, Applicant: Entellus Medical, Inc., Form PCT/IB/326, dated Oct. 30, 2006 (4 pages).
Medtronic, ENT Image-Guided Surgery System, http://www.xomed.cipm/xomed_products_element.html, Jun. 3, 2009 (2 pages).
International Search Report dated Aug. 2, 2010, for PCT/US2010/037508, Applicant: Entellus Medical, Inc. (4 pages).
Written Opinion of the International Search Authority dated Aug. 2, 2010, for PCT/US2010/037508, Applicant: Entellus Medical, Inc. (4 pages).
International Preliminary Report on Patentability dated Jul. 30, 2009, for PCT/US2007/088834, Applicant: Entellus Medical, Inc. (12 pages).
PCT International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty) for PCT/US2010/037508, Applicant: Entellus Medical Inc., Form PCT/IB/326 and 373, dated Dec. 15, 2011 (6pages).
Extended European Search Report dated Oct. 23, 2012 issued by the European Patent Office in EP Application No. 10784199.1-1526 /2437843 PCT/US2010037508, Applicant: Entellus Medical, Inc., (6pages).
Notification of First Office Action dated Apr. 2, 2013 issued by the Chinese Patent Office in Chinese Patent Application No. 201080024851.X, Applicant: Entellus Medical, Inc., (7pages), including an English translation prepared by Kangxin Partners, P.C. (7pages).
The extended European search report dated Jan. 21, 2016 in European Application No. 15184180.6-1501, (6pages).
Communication under Rule 71(3) EPC issued by the European Patent Office dated May 21, 2015 in European Patent Application No. 10 784 199.1-1506, Applicant: Entellus Medical, Inc., (6pages).
Notification of the Second Office Action issued by the the State Intellectual Property Office of P.R.C. dated Dec. 25, 2013 in Chinese Patent Application No. 201080024851.X including English Translation prepared by Kangxin Partners, Applicant: Entellus Medical, Inc., (5pages).
Notification of the Third Office Action issued by the the State Intellectual Property Office of P.R.C. dated Jul. 15, 2014 in Chinese Patent Application No. 201080024851.X including English Translation prepared by Kangxin Partners, Applicant: Entellus Medical, Inc., (8pages).
Notice of Rejection issued by the Japanese Patent Office dated Mar. 18, 2014 in Japanese Patent Application No. 2012-514199 including English Translation prepared by Kita-Aoyama International Patent Bureau, Applicant: Entellus Medical, Inc., (4pages).
Decision of Rejection issued by the Japanese Patent Office dated Sep. 2, 2014 in Japanese Patent Application No. 2012-514199 including English Translation prepared by Kita-Aoyama International Patent Bureau, Applicant: Entellus Medical, Inc., (3pages).
Notice of Allowance issued by the Japanese Patent Office dated May 12, 2015 in Japanese Patent Application No. 2012-514199 including English Translation prepared by Kita-Aoyama International Patent Bureau, Applicant: Entellus Medical, Inc., (4pages).
Office Action dated Sep. 19, 2017 in U.S. Appl. No. 15/345,322, (51pages).
Office Action dated Mar. 22, 2017 in U.S. Appl. No. 15/345,322, (47pages).
Office Action dated Apr. 24, 2018 in U.S. Appl. No. 15/345,322, (26pages).
Communication pursuant to Article 94(3) EPC dated May 4, 2018 in European Patent Application No. 15184180.6-1132, Applicant: Entellus Medical, Inc., (4pages).
Fiber-optic Surgical Probe, http://www.anthonyproducts.com/store/p-389-fiber-optic-surgical-probe.aspx, 1 page, at least as early as Jul. 12, 2011.
Light Probe Kit, http://www.fiberoptix.com/products/light-probe-kit.html, 2 pages, Apr. 2010.
Related Publications (1)
Number Date Country
20170050001 A1 Feb 2017 US
Continuations (4)
Number Date Country
Parent 14524889 Oct 2014 US
Child 15139052 US
Parent 13644538 Oct 2012 US
Child 14524889 US
Parent 13116712 May 2011 US
Child 13644538 US
Parent 12479521 Jun 2009 US
Child 13116712 US